Document is current

Article History

Received: 1 February 2024

Revised: 29 May 2024

Accepted: 14 June 2024

First Online: 5 July 2024

Declarations

:

: The study protocol was approved by the local Ethics Committee of the University Frankfurt, Germany (2022 − 899) and followed the tenets of the Declaration of Helsinki.

: Due to the retrospective nature of this trial no patient consent was needed.

: T. Kohnen: Consultant and Research for Alcon/Novartis, J&J, Lensgen, Oculentis, Oculus, Presbia, Schwind, Zeiss. Consultant for Allergan, Bausch & Lomb, Geuder, Med Update, Santen, Staar, Thieme, Ziemer. All other authors have no financial interests to disclose.